2023 annual financial data
Design Therapeutics 2023 Operating margin
Design Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -78,190,000 USD and net income was -66,862,000 USD.
Operating cash flow was -58,560,000 USD.
Get free Design Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -78,190,000 USD
- Net income
- -66,862,000 USD
- Operating cash flow
- -58,560,000 USD